Physical Biochemistry and Biology of Amyloid Beta-Protein
Physical Biochemistry and Biology of Amyloid Beta-Protein
批准号:
8332301
负责人:
DAVID B. TEPLOW
金额:
$31.57万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-15 至 2016-08-31
关键词:
Alzheimer&aposs DiseaseAmyloidAmyloid ProteinsAmyloid beta-ProteinBiochemistryBioinformaticsBiologicalBiologyCell LineCerealsCircular DichroismCountryDevelopmentDiseaseDrosophila eyeEye DevelopmentFluorescenceFoundationsGenesGoalsHumanHydroxyl RadicalIn VitroLeadLifeLocomotionLongevityMass Spectrum AnalysisModelingMolecular ConformationMutagenesisNeuronsNeurotoxinsPathologicPeptidesPrintingProteinsProteolysisResearchResolutionScanningSeedsSeminalSolventsSpectrum AnalysisStructureStructure-Activity RelationshipSystemTherapeuticTherapeutic AgentsThioflavin TTimeTissue-Specific Gene ExpressionUnited StatesWorkagedcrosslinkcytotoxicfootin vivoinsightion mobilitylight scatteringmolecular dynamicsmultidisciplinaryneurotoxicnovelpeptide Apreventresearch clinical testingsenescencestructural biologytau Proteins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a devastating disease of the aged. Two amyloid-forming proteins are associated with AD, the amyloid ?-protein (A?) and tau. Recent evidence supports an hypothesis, the "amyloid cascade hypothesis," that posits that A? oligomers are the seminal neuropathogenetic agents in AD. The overall goal of this proposal is to understand the structural biology of A?, and fragments thereof, and to establish formal structure-activity relationships. In the long run, we seek to obtain an atomic-resolution determination of the structure of the proximate neurotoxins formed by A?, and in doing so, enable the development, for the first time, of disease-modifying AD treatments. A multidisciplinary strategy, employing complementary experimental and computational approaches, will be employed. This strategy has been used very successfully in the past, providing novel insights into the A? system. Three specific aims are proposed that systematically and logically progress from in vitro biophysical studies of A? and its oligomeric assemblies (Aim 1), to in vitro and in vivo studies of the biological activity of selected such assemblies (Aim 2), to determination of the effects of selected assemblies on differential gene expression in neurons (Aim 3). Taken together, these studies will provide the theoretical and experimental foundation for subsequent therapeutic compound development and clinical testing in humans. Aim 1. To determine the structural dynamics of A? and tau assembly. a. To use scanning Tyr mutagenesis to elucidate mechanisms of A? oligomerization. b. To determine the dynamics of intramolecular turn formation and its effects on A? assembly. c. To determine the effects of primary structure changes on the conformations and assembly dynamics of biologically relevant and theoretically important A? peptides. Aim 2. To determine the biological effects of A? assemblies. a. To determine the cytotoxic effects of A? assemblies on cultured neuronal cell lines and primary neurons. b. To determine the effects of A? assemblies on Drosophila eye development, locomotion, and longevity. Aim 3. To identify and validate AD-relevant genes using a bioinformatics approach that considers A? assembly structure, neuron type, and neuron senescence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Physical Biochemistry and Biology of Amyloid Beta-Protein
-
批准号:8531820
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2011
-
负责人:DAVID B. TEPLOW
-
依托单位:
Physical Biochemistry and Biology of Amyloid Beta-Protein
-
批准号:8850772
-
项目类别:
-
资助金额:$30.62万
-
财政年份:2011
-
负责人:DAVID B. TEPLOW
-
依托单位:
Physical Biochemistry and Biology of Amyloid Beta-Protein
-
批准号:8222749
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2011
-
负责人:DAVID B. TEPLOW
-
依托单位:
Physical Biochemistry and Biology of Amyloid Beta-Protein
-
批准号:8722423
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2011
-
负责人:DAVID B. TEPLOW
-
依托单位:
SIMULATION OF AMYLOID BETA-PROTEIN FOLDING AND ASSEMBLY
-
批准号:7724408
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2008
-
负责人:DAVID B. TEPLOW
-
依托单位:
SIMULATION OF AMYLOID BETA-PROTEIN FOLDING AND ASSEMBLY
-
批准号:7627780
-
项目类别:
-
资助金额:$2.01万
-
财政年份:2007
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7663805
-
项目类别:
-
资助金额:$153.53万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7279127
-
项目类别:
-
资助金额:$149.23万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7080008
-
项目类别:
-
资助金额:$154.72万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
PHYSICAL BIOCHEMISTRY AND BIOLOGY OF AMYLOID B-PROTEIN
-
批准号:7112180
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7469486
-
项目类别:
-
资助金额:$150.19万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROTEIN CHEMISTRY CORE
-
批准号:7112179
-
项目类别:
-
资助金额:$26.67万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7903270
-
项目类别:
-
资助金额:$155.27万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE CLC SEQUENCING SYST: MULTIPLE SCLEROSIS, EXPERIMENTAL AUTOIMMUNE ENCEPHA
-
批准号:6973352
-
项目类别:
-
资助金额:$5.53万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE CLC SEQUENCING SYST: ALZHEIMER'S DISEASE
-
批准号:6973351
-
项目类别:
-
资助金额:$11.06万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE cLC Sequencing System 2 Cart w/PC
-
批准号:6730937
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE CLC SEQUENCING SYST: OSTEOPOROSIS
-
批准号:6973353
-
项目类别:
-
资助金额:$0.92万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE CLC SEQUENCING SYST: PARKINSON'S DISEASE
-
批准号:6973354
-
项目类别:
-
资助金额:$0.92万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
Formation and Function of Prefibrillar ABeta Assemblies
-
批准号:7125471
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2003
-
负责人:DAVID B. TEPLOW
-
依托单位:
Formation and Function of Prefibrillar ABeta Assemblies
-
批准号:7122656
-
项目类别:
-
资助金额:$46.37万
-
财政年份:2003
-
负责人:DAVID B. TEPLOW
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: